JAID/JSC Guidelines for Infection Treatment 2015-Intestinal infections

J Infect Chemother. 2018 Jan;24(1):1-17. doi: 10.1016/j.jiac.2017.09.002. Epub 2017 Oct 3.

Authors

Japanese Association for Infectious Disease/Japanese Society of Chemotherapy; JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee; Intestinal Infections Working Group (WG); Kenji Ohnishi¹, Yusuke Ainoda², Akifumi Imamura³, Sentaro Iwabuchi⁴, Masumi Okuda⁵, Takashi Nakano⁶

Affiliations

¹ Tokyo Metropolitan Health and Medical Corporation Ebara Hospital, Tokyo, Japan.
² Tokyo Metropolitan Health and Medical Corporation Ebara Hospital, Tokyo, Japan; Department of Infectious Diseases, Tokyo Women's Medical University, Japan.
³ Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.
⁴ Department of Infectious Diseases, Tokyo Metropolitan Bokutoh General Hospital, Tokyo, Japan.
⁵ Department of Pediatrics, Sasayama Medical Center, Hyogo College of Medicine, Sasayama, Hyogo, Japan.
⁶ Department of Pediatrics, Kawasaki Medical School, Okayama, Japan.

PMID: 28986191
DOI: 10.1016/j.jiac.2017.09.002

No abstract available

Publication types

Practice Guideline

MeSH terms

Bacterial Infections / drug therapy*
Bacterial Infections / microbiology
Community-Acquired Infections / drug therapy
Community-Acquired Infections / microbiology
Community-Acquired Infections / parasitology
Community-Acquired Infections / virology
Cross Infection / drug therapy
Cross Infection / microbiology
Cross Infection / parasitology
Cross Infection / virology
Humans
Intestinal Diseases / drug therapy*
Intestinal Diseases / microbiology
Intestinal Diseases / parasitology
Intestinal Diseases / virology
Intestinal Diseases, Parasitic / drug therapy*
Intestinal Diseases, Parasitic / parasitology
Virus Diseases / drug therapy*
Virus Diseases / virology